Navigation Links
REVEAL(R) RegistryData May Advance Patient Care in Pulmonary Arterial Hypertension
Date:5/17/2010

pathways (the prostacyclin pathway; the endothelin pathway; and the nitric oxide pathway) [2]. The available therapies have shown positive treatment effects in patients with PAH, but they do not provide a cure, and in many patients the disease will progress. PAH remains a serious life-threatening condition [2,3]. Early recognition and an understanding of the selection and timing of therapeutic options remain critical elements in the optimal management of PAH patients.

References

1. Farber HW; Loscalzo J. Mechanisms of disease: pulmonary arterial hypertension. N. Eng. J. Med. 2004; 351:1655-65.

2. Humbert M; Sitbon O; Simonneau G. Treatment of pulmonary arterial hypertension. N. Eng. J. Med. 2004;351:1425-36.

3. Humbert M; Morrell NW; Archer SL; et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 2004; 43: Suppl. 12: 13S-24S. 

About the REVEAL® Registry

The REVEAL Registry is a multi-center, observational, U.S.-based study of the clinical course and disease management of patients with PAH. Approximately 3,500 previously and newly diagnosed patients from over 50 participating centers across the United States have been enrolled and tracked in the REVEAL Registry. Patients are followed for a minimum of five years from the time of enrollment. The registry has enrolled consenting newly diagnosed or previously diagnosed patients with World Health Organization (WHO) Group I PAH, who meet specific hemodynamic criteria based upon prior performance of right heart catheterization. The REVEAL Registry is sponsored by Actelion Pharmaceuticals. For more information, please visit

SOURCE Actelion Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
6. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
7. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
8. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
9. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
10. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
11. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Sept. 30, 2014  HealthLoop® released an app version ... in iOS 8 and allows people to share medical ... harnesses native iOS technologies to enhance the HealthLoop experience ... connection with their doctors between visits. ... data they collect is exciting," says HealthLoop founder Dr. ...
(Date:9/30/2014)... Sept. 30, 2014 BioStructures, LLC has ... Association of Tissue Banks (AATB), it was announced ... Officer. Accreditation follows an intensive nine-month ... trained AATB inspector.  It establishes that the level ... facility meets or exceeds the standards set by ...
(Date:9/30/2014)... VIEW, Calif. , Sept. 30, 2014 /PRNewswire/ ... tissue diagnostics market, Frost & Sullivan recognizes Ventana ... Roche Group, with the 2014 North American Frost ... to strict quality practices along with a focus ... Ventana a global leader in tissue-based cancer diagnostic ...
Breaking Medicine Technology:HealthLoop Integrates with Apple's HealthKit Enabling Patients to Share Health Data with Their Doctors Right from their iPhone 2Biostructures, LLC Earns AATB Accreditation 2Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 2Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 3Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 4
... SAN RAMON, Calif., Nov. 29, 2011 Odyssey ... biologically-relevant pathways in human cells, announced today that ... a laser-based confocal imaging platform from GE Healthcare, ... Odyssey Thera applies a systems ...
... Nov. 29, 2011 A new study in The ... a novel mechanism that cancer cells may use to escape ... cells induce tumor cell resistance to cytotoxic T cells in ... Center in Tampa, Fla., shows that a specific type of ...
Cached Medicine Technology:Odyssey Thera is First to Install Next Generation High-Content Imaging Capability 2New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System 2New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System 3
(Date:9/30/2014)... Asheville, North Carolina (PRWEB) September 30, 2014 ... cloud readiness and IT Infrastructure analytics across data ... announced it has achieved an important milestone of ... problems and plan for important projects such as ... workload migrations. , The strong customer engagement ...
(Date:9/30/2014)... Washington DC. (PRWEB) September 30, 2014 ... has developed Lyricz iPhone App for another great social ... release of LYRICZ App for iPhone®, iPad®, and iPod ... 30 second snippets of music from their pre-populated ITunes ... associate the chosen song’s album art or photo of ...
(Date:9/30/2014)... Albany, New York (PRWEB) September 30, 2014 ... Research, a U.S.-based market intelligence agency states that the ... a value of USD 18.5 billion by the end ... was valued at USD 10.3 billion in 2012, will ... develop into a USD 18.5 billion worth market by ...
(Date:9/30/2014)... 2014 MyServer2Go.com made an ... Best VPS Hosting this year for its quality VPS ... price. , MyServer2Go.com is a professional and targeted ... services. And this announcement will help webmasters find the ... MyServer2Go.com, Arvixe ( http://www.arvixe.com ) is one of the ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Speaking on ... OMICS Group observed ‘Nursing Conference’ as a remarkable event, ... and medium medical and clinical research and diagnostic companies, ... conference as a perfect platform to share experience, foster ... around the world. Nursing Conference is a forum to ...
Breaking Medicine News(10 mins):Health News:RISC Networks Becomes First SaaS Cloud Readiness and IT Infrastructure Analytics Vendor to Surpass Milestone of 5,000 Engagements 2Health News:RISC Networks Becomes First SaaS Cloud Readiness and IT Infrastructure Analytics Vendor to Surpass Milestone of 5,000 Engagements 3Health News:LYRICZ App for iPhone®, Helps You Share Images with Music to Inspire and Influence 2Health News:Global Medical Imaging Reagents Market Segment up to 2019: Transparency Market Research 2Health News:Global Medical Imaging Reagents Market Segment up to 2019: Transparency Market Research 3Health News:Arvixe Is Named Best VPS Hosting by MyServer2Go.com 2Health News:Exploring New Possibilities to Take Nursing Profession to Great Heights 2Health News:Exploring New Possibilities to Take Nursing Profession to Great Heights 3
... way deter the elders from chatting or surfing the Internet ... net on par// with the youngsters. ,The survey conducted ... Marketing Services has revealed that senior netizens are a fast-growing ... million by 2008. ,These seniors - who number ...
... very common in North America with an estimated 400,000 people ... these //people have their hearts pumping again and only 6 ... causes of death after the heart is restarted is brain ... Society for Academic Emergency Medicine Annual Meeting, May 18-21, in ...
... get themselves screened for HIV, city-run medical clinics have relaxed ... the new rule, counseling sessions and written informed consent is ... is a verbal consent from the patient. ,This ... relaxed with respect to consent and counseling. Two hospitals and ...
... have issued a warning to drug users about the quality ... is being sold on the west coast// of Scotland has ... the beginning of this year there has been 82 inquiries ... same period last year. The police have said that not ...
... say may fight two dangerous germs that bedevil hospitals//. ... Laboratories and his colleagues looked at 250,000 extracts from ... from around the world, the health portal HealthDay News ... African soil, which they say could fight staph an ...
... Following high incidence of a potentially dangerous infection associated ... Bausch & Lomb//, those in Hong Kong, US and ... controversial product has been withdrawn from sales. ... product. However the company has been unable to claim ...
Cached Medicine News:Health News:Elders Too Are Keen To Chat On Internet On Par With Youngsters 2Health News:Survival After Cardiac Arrest Is Aided By Cooling 2
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Kleinert-Kutz Single Skin Hook, Large...
Medicine Products: